AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
+31.97%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$1.12B
AUM Growth
-$319M
(-22%)
Cap. Flow
-$574M
Cap. Flow
% of AUM
-51.07%
Top 10 Holdings %
Top 10 Hldgs %
21.26%
Holding
360
New
82
Increased
64
Reduced
136
Closed
54
Top Buys
| 1 |
AbbVie
ABBV
|
$17M |
| 2 |
Broadridge
BR
|
$15.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
$13.4M |
| 4 |
Dominion Energy
D
|
$10.7M |
| 5 |
D.R. Horton
DHI
|
$10.2M |
Top Sells
| 1 |
CORE
Core Mark Holding Co., Inc.
CORE
|
$31.7M |
| 2 |
Rio Tinto
RIO
|
$29.1M |
| 3 |
Zurn Elkay Water Solutions
ZWS
|
$28.7M |
| 4 |
Cannae Holdings
CNNE
|
$27.4M |
| 5 |
Microsoft
MSFT
|
$25.7M |
Sector Composition
| 1 | Consumer Discretionary | 17.12% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14% |
| 4 | Industrials | 10.56% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
BioMarin Pharmaceuticals
BMRN
$11.1B
| $338K | 0.03% |
+2,743
| New | +$338K |
|
277
Itron
ITRI
$5.51B
| $329K | 0.03% |
4,972
-12,431
| -71% | -$823K |
|
278
Houlihan Lokey
HLI
$13.9B
| $322K | 0.03% |
5,786
-1,545
| -21% | -$86K |
|
279
Protolabs
PRLB
$1.19B
| $316K | 0.03% |
+2,814
| New | +$316K |
|
280
Fifth Third Bancorp
FITB
$30.2B
| $315K | 0.03% |
16,360
| – | – |
|
281
Novo Nordisk
NVO
$245B
| $315K | 0.03% |
9,630
-2,088
| -18% | -$68.3K |
|
282
Vanguard FTSE All-World ex-US ETF
VEU
$48.8B
| $311K | 0.03% |
6,535
| – | – |
|
283
Molina Healthcare
MOH
$9.47B
| $303K | 0.03% |
+1,704
| New | +$303K |
|
|
CERN
284
DELISTED
Cerner Corp
CERN
| $301K | 0.03% |
4,388
-18
| -0.4% | -$1.24K |
|
285
AllianceBernstein
AB
$4.36B
| $299K | 0.03% |
10,970
| – | – |
|
|
HZNP
286
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $295K | 0.03% |
5,309
-16,349
| -75% | -$908K |
|
287
DocuSign
DOCU
$16.1B
| $282K | 0.03% |
1,639
-2,920
| -64% | -$502K |
|
|
AVLR
288
DELISTED
Avalara, Inc.
AVLR
| $279K | 0.02% |
2,096
-1,929
| -48% | -$257K |
|
289
Gladstone Investment Corp
GAIN
$543M
| $276K | 0.02% |
26,982
| – | – |
|
290
Stride
LRN
$7.01B
| $272K | 0.02% |
10,000
| – | – |
|
291
Alnylam Pharmaceuticals
ALNY
$59.4B
| $268K | 0.02% |
1,809
-632
| -26% | -$93.6K |
|
292
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.85B
| $258K | 0.02% |
+4,935
| New | +$258K |
|
293
Advanced Micro Devices
AMD
$245B
| $257K | 0.02% |
4,882
-1,293
| -21% | -$68.1K |
|
294
Incyte
INCY
$16.9B
| $253K | 0.02% |
+2,437
| New | +$253K |
|
295
Cognex
CGNX
$7.43B
| $248K | 0.02% |
+4,154
| New | +$248K |
|
296
Middleby
MIDD
$7.32B
| $248K | 0.02% |
+3,146
| New | +$248K |
|
297
SBA Communications
SBAC
$21.2B
| $246K | 0.02% |
827
-945
| -53% | -$281K |
|
298
ITT
ITT
$13.3B
| $239K | 0.02% |
+4,067
| New | +$239K |
|
299
W.W. Grainger
GWW
$47.5B
| $235K | 0.02% |
+747
| New | +$235K |
|
300
DexCom
DXCM
$31.6B
| $231K | 0.02% |
2,280
-5,084
| -69% | -$515K |
|